Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection
Name:
110714_Maher_Crunch-time-for-f ...
Size:
94.72Kb
Format:
PDF
Description:
Main article
Affiliation
MRC⁄ UVRI Uganda Research Unit on AIDS, Entebbe, Uganda; London School of Hygiene and Tropical Medicine, London, UK; Medecins sans Frontieres, Geneva, Switzerland; Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA, USAIssue Date
2011-07-15
Metadata
Show full item recordPublisher
Wiley-BlackwellPubMed ID
21762306Type
ArticleLanguage
enISSN
1742-1241ae974a485f413a2113503eed53cd6c53
10.1111/j.1742-1241.2011.02697.x
Scopus Count
Collections
Related articles
- Funding for HIV/AIDS needs to double to ensure universal access to drugs.
- Authors: Dyer C
- Issue date: 2009 Feb 11
- [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
- Authors: Kazatchkine M, Moatti JP
- Issue date: 2008 Dec
- Ensuring access to essential medicines: some economic considerations.
- Authors: Maskus KE
- Issue date: 2003 Jul
- Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
- Authors: Moatti JP, N'Doye I, Hammer SM, Hale P, Kazatchkine M
- Issue date: 2003 Dec
- Improving access to essential drugs for people living with HIV/AIDS.
- Authors: Balasubramaniam K
- Issue date: 2000 Jan-Mar